0001104659-20-041158.txt : 20200331 0001104659-20-041158.hdr.sgml : 20200331 20200331161245 ACCESSION NUMBER: 0001104659-20-041158 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20200331 DATE AS OF CHANGE: 20200331 EFFECTIVENESS DATE: 20200331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 20761924 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 DEFA14A 1 tm2014295-2_defa14a.htm DEFA14A

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )

 

 

 

 

Filed by the Registrant x
 
Filed by a Party other than the Registrant o
 
Check the appropriate box:
o Preliminary Proxy Statement
o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o Definitive Proxy Statement
x Definitive Additional Materials
o Soliciting Material under §240.14a-12
 
INNOVIVA, INC.
(Name of Registrant as Specified In Its Charter)
 
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
x No fee required.
o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1) Title of each class of securities to which transaction applies:
     
  (2) Aggregate number of securities to which transaction applies:
     
  (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
     
  (4) Proposed maximum aggregate value of transaction:
     
  (5) Total fee paid:
     
o Fee paid previously with preliminary materials.
o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1) Amount Previously Paid:
     
  (2) Form, Schedule or Registration Statement No.:
     
  (3) Filing Party:
     
  (4) Date Filed:
     

 

 

 

 

 

 

1350 Old Bayshore Highway, Suite 400
Burlingame, California 94010

ADDITIONAL INFORMATION REGARDING THE

ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON APRIL 24, 2020

 

The following Notice of Change of Location relates to the proxy statement (the “Proxy Statement”) of Innoviva, Inc. (the “Company”), dated March 11, 2020, furnished to stockholders of the Company in connection with the solicitation of proxies by the Board of Directors of the Company (the “Board”) for use at the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) to be held on Friday, April 24, 2020. This Supplement is being filed with the Securities and Exchange Commission to provide notice of a change of location of the Annual Meeting and is being made available to stockholders on or about March 31, 2020.

 

THE NOTICE SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT.

 

NOTICE OF CHANGE OF LOCATION

OF ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON APRIL 24, 2020

March 31, 2020

 

To the Stockholders of Innoviva, Inc.:

 

Due to the public health impact of the coronavirus pandemic and to support the health and well-being of our stockholders and other stakeholders, NOTICE IS HEREBY GIVEN that the location of the 2020 Annual Meeting of Stockholders of Innoviva, Inc. (the “Company”) has been changed. As previously announced, the Annual Meeting will be held on Friday, April 24, 2020 at 10:00 a.m. Eastern Time. In light of public health concerns regarding the coronavirus pandemic, the Annual Meeting will be held in a virtual meeting format only. You will not be able to attend the Annual Meeting in person.

 

As described in the proxy materials for the Annual Meeting previously distributed, the Board fixed the close of business on March 6, 2020 as the record date for the determination of stockholders entitled to notice of and to vote at the Annual Meeting or any postponement or adjournment thereof. Record holders of shares of the Company’s common stock, par value $0.01 per share, at the close of business on the record date are entitled to notice of and to vote at the Annual Meeting. To be admitted to the Annual Meeting at www.virtualshareholdermeeting.com/INVA2020, you must enter the control number found on your proxy card, voting instruction form or notice you previously received. You may vote during the Annual Meeting by following the instructions available on the meeting website during the meeting.

 

For further information regarding the matters to be acted upon at the Annual Meeting, I urge you to carefully read the Proxy Statement. The Company makes proxy materials available to our stockholders on the Internet. You can access proxy materials at http://investor.inva.com/proxy.cfm. You also may authorize your proxy via the Internet or by telephone by following the instructions on that website. In order to authorize your proxy via the Internet or by telephone, you must have the stockholder identification number that appears on the materials sent to you.

 

  By Order of the Board of Directors,
   
  /s/ Geoffrey Hulme
  Geoffrey Hulme
  Interim Principal Executive Officer

  

 

 

GRAPHIC 2 tm2014295-2_defa14aimg01.jpg GRAPHIC begin 644 tm2014295-2_defa14aimg01.jpg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end